HERZUMA subst sèche 440 mg c solv flac
7680678920010
CH-67892
L01FD01
07.16.1.
Reimbursement limitations:
HERZUPERJ.01
HERZUMA en association avec le pertuzumab (PERJETA) comme traitement adjuvant du cancer du sein
Les …
1 / 3
google
Details
- Product number
- 6789201
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- Praeparatio cryodesiccata: trastuzumabum 440 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. Solvant (i.v.): alcohol benzylicus 0.22 g, aqua ad iniectabile, q.s. ad solutionem pro 20 ml.
Articles (1)
Herzuma 440 mg, poudre pour solution à diluer pour perfusion
Puder
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
440.0 MG | Substance | Wirkstoff (Principe actif) |
|
SOLIV
|
0.22 G | Substance | Konservierungsstoff (Conservateur) |
|
PRC
|
- | Substance | HNIDK |
|
SOLIV
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1469.00
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2021
Authorization holder
IQONE HEALTHCARE SWITZERLAND
1290 Versoix
Authorization information
- Swissmedic authorization number
- 67892
- Drug name
- Herzuma, poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- L01FD01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 13/07/2021
- Authorization expiration date
- 13/07/2026
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HERZUMA subst sèche 440 mg c solv flac
- Description (DE)
- HERZUMA Trockensub 440 mg c Solv Durchstf
- Market launch
- 13/07/2021
- Narcotic (BTM)
- No